Prostate cancer (PCa) is the most common worldwide diagnosed malignancy in male
population. The diagnosis, the identification of aggressive disease, and the post-treatment …

Based on the advantages of revealing the functional status and molecular expression of
tumor cells, positron emission tomography (PET) imaging has been performed in numerous …

Prostate-specific membrane antigen (PSMA) positron emission tomography/computed
tomography (PET/CT) has emerged as an important imaging technique for prostate cancer …

Background PET-based radiomics features could predict the biological characteristics of
primary prostate cancer (PCa). However, the optimal thresholds to predict the biological …

Artificial intelligence (AI) has evolved significantly in the past few decades. This thriving
trend has also been seen in medicine in recent years, particularly in the field of imaging …

Introduction Accurate imaging is essential for staging prostate cancer and guiding
management decisions. Conventional imaging modalities are hampered by a limited …

Radiotheranostics refers to the pairing of radioactive imaging biomarkers with radioactive
therapeutic compounds that deliver ionizing radiation. Given the introduction of very …

Introduction In the last decade, two new radionuclide-based therapies, 223Radichloride and
radioligand therapy (RLT) targeting prostate-specific membrane antigen (PSMA), have been …

The importance of machine learning (ML) in the clinical environment increases constantly.
Differentiation of pathological from physiological tracer-uptake in positron emission …

Introduction This study was conducted to evaluate the predictive values of volumetric
parameters and radiomic features (RFs) extracted from pretreatment 68Ga-PSMA PET and …